70 Gy or more: which dose for which prostate cancer? U. GanswindtF. PaulsenC. Belka Review 11 May 2005 Pages: 407 - 419
The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status Wolfgang J. KöstlerThomas BrodowiczChristoph C. Zielinski Original Paper 29 April 2005 Pages: 420 - 428
Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization Shuang-Jian QiuLina LuC. Andrew Bonham Original Paper 08 April 2005 Pages: 429 - 438
Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women Malin BergmanMarie AhnströmSten Wingren Original Paper 10 May 2005 Pages: 439 - 444
Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma Ken NakataniTakeshi WadaShigeyuki Fujita Original Paper 26 April 2005 Pages: 445 - 452
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma T. ValkovićD. FučkarN. Jonjić Original Paper 10 May 2005 Pages: 453 - 458
The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation A DanielssonE KarlssonC Mercke Original Paper 18 March 2005 Pages: 459 - 467
Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response Jianping PanMinghui ZhangXuetao Cao Original Paper 12 February 2005 Pages: 468 - 478
Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC) Dorota DworakowskaEwa JassemEugenia Częstochowska Original Paper 05 April 2005 Pages: 479 - 485